A Pilot Study Looking At The Use Of Alfuzosin In The Treatment Of Bladder Dysfunction In Patients With Multiple Sclerosis
Phase of Trial: Phase II/III
Latest Information Update: 16 May 2015
At a glance
- Drugs Alfuzosin (Primary)
- Indications Bladder dysfunction
- Focus Therapeutic Use
- 23 Jun 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Feb 2009 Planned end date changed from Nov 2008 to Nov 2009 as reported by ClinicalTrials.gov.
- 25 Jun 2008 New trial record.